Dupilumab and COVID‐19: What should we expect?

Coronavirus disease 2019 (COVID‐19) is a pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with high morbidity and mortality. There are very limited data on the interference of immunomodulating drugs on the risk of infection and on the course of the disease. In...

Full description

Saved in:
Bibliographic Details
Published in:Dermatol Ther
Main Authors: Patruno, Cataldo, Stingeni, Luca, Fabbrocini, Gabriella, Hansel, Katharina, Napolitano, Maddalena
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2020
Subjects:
Short Papers
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7267436/
https://ncbi.nlm.nih.gov/pubmed/32362061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13502
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items